OREX Financial Facts

Total other income (expense): -195K
Loss from operations: -10.95M
See Full Income Statement

Commitments and contingencies: 0
Cash and cash equivalents: 154.27M
See Full Balance Sheet

Orexigen Therapeutics (OREX) Earnings

  |   Expand Research on OREX
Next EPS Date 2/25/16 *Est. EPS Growth Rate -200.0% *Last Qtr.
Average EPS % Beat Rate -15.5% Revenue Growth Rate -67.6% *Last Qtr.
Average % Move 1-Wk after EPS +0.0% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/5/15 Q315 -$0.09-$0.16 +$0.07$10M$12.17M N/A Details
8/6/15 Q215 -$0.18-$0.17 -$0.01$5.2M$4.92M N/A Details
5/8/15 Q115 -$0.14-$0.14 $0.00$4.36M$7.28M N/A Details
2/25/15 Q414 $0.00$0.21 -$0.21$22.95M$49.65M N/A Details
11/10/14 Q314 $0.09-$0.13 +$0.22$30.9M$8.93M N/A Details
8/7/14 Q214 -$0.21-$0.21 $0.00$857K$1M N/A Details
3/12/14 Q413 -$0.21-$0.19 -$0.02$857M$900M N/A Details
11/12/13 Q313 -$0.19-$0.18 -$0.01$857K$800K N/A Details